Clinical Trial Update: A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML. [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing two induction chemotherapy regimens for acute myeloid leukemia (HDAC vs AD), currently enrolling by invitation at Asan Medica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Asan Medical Center | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: ENROLLING_BY_INVITATION